News: Deals: Reports

Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Mutual Funds Taxes Ask the Expert Money 101 Autos Loan Center Best Places to Live Ask the Expert Millionaires in the Making Ultimate Guide to Retirement Retirement Calculators Best Funds Ask the Mole Best Places to Retire Personal Tech Big Tech Blog Techland Blog Sectors and Stocks Fortune 500 Techs Tech Talk 100 Best Places to Launch Ultimate Resource Guide Small Biz Makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts

Teva-Generic Pharmaceutical Products Portfolio & Watson Pharmaceuticals Inc	Update Date: 12/29/08
Date Announced: 11/25/08
Value (million $USD): 36.0 million U.S. Dollar 143.3 million Israeli Shekel

Status: Pending

TRANSACTION DETAILS
Date Announced	11/25/08
Date Originally Announced	11/25/08
Format	Acq. of Assets	Acquisition techniques	Divestiture
Attitude	Friendly	Agency	n/a
Value	36.0 million U.S. Dollar 143.3 million Israeli Shekel	Advisor Fees	n/a

SYNOPSIS
ISRAEL - Watson Pharmaceuticals Inc of the US definitively agreed to acquire the generic pharmaceutical products portfolio of Teva Pharmaceutical Industries Ltd, a manufacturer of pharmaceutical products, for 143.28 mil Israeli shekels ($36 mil US).

TARGET
Name	Teva-Generic Pharmaceutical Products Portfolio
Industries	Medicinal chemicals and botanical products; Biological products, except diagnostic substances
City	n/a
State	n/a
Nation	Israel
Incorporated in	n/a
Public Status	Subsidiary
Business Description	The generic pharmaceutical products portfolio of Teva Pharmaceutical Industries Ltd, located in Israel, is manufactures pharmaceutical products. Its key products in the portfolio include Cyclosporine Capsules and Liquid, Desmopressin Acetate Tablets, Glipizide/Metformin HCL Tablets, Mirtazapine Orally Disintegrating Tablets and Metoclopramide HCL Tablets.
Advisors	NULL
Target Sales	n/a

ACQUIROR
Name	Watson Pharmaceuticals Inc (WPI)
Industries	Medicinal chemicals and botanical products; Biological products, except diagnostic substances
City	Corona
State	CA
Nation	United States
Incorporated in	NV
Public Status	Public
Business Description	Watson Pharmaceuticals Inc, located in Corona, California, is a pharmaceutical manufacturing firm. It develops, manufactures, markets, sells and distributes generic and specialty brand pharmaceutical products. The company was founded in 1984.
Advisors	NULL
Acquiror Sales	2.52 billion U.S. Dollar

Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer

Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.